<DOC>
	<DOCNO>NCT01521520</DOCNO>
	<brief_summary>Type 1 diabetes result autoimmune destruction insulin-producing beta cell islet Langerhans pancreas . Initially , diabetes usually clinically silent immune cell invade pancreatic islet , process term insulitis , eventually lead loss beta cell islet . If enough beta cell destroy , body make enough insulin maintain blood sugar normal range clinical diabetes develops . The purpose study assess ability magnetic resonance image ferumoxytol detect change pancreas associate insulitis type 1 diabetes .</brief_summary>
	<brief_title>Imaging Type 1 Diabetes Progression</brief_title>
	<detailed_description>This study design monitor change associate development autoimmune diabetes . A magnetic resonance imaging ( MRI ) base technique use noninvasively measure change within pancreas associate development autoimmune diabetes . The iron-containing drug ferumoxytol use intravenous MRI contrast agent study . Individuals ask participate one time , 1-year , 2-year period . During development phase study , image series consist 3 MRI scan . At initial image visit pre-ferumoxytol scan do , follow ferumoxytol injection , immediate post-injection scan . The subsequent scan conclude within 96 hour ferumoxytol injection ( typically 48 hour ) . Those participate 1-year repeat image approximate time 0 , 6 month , 12 month . Those participate 2-years repeat image approximate time 0 , 3 , 6 , 12 , 18 , 24 month enrollment . Measurements autoimmunity metabolic parameter ( collect part collaborate diabetes clinical study ) use data analysis longitudinal portion study . Stimulated C-peptide measure marker endogenous insulin production capacity beta-cell mass .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Ferrosoferric Oxide</mesh_term>
	<criteria>Participation collaborate diabetes clinical trial Able understand write consent document HIPAA authorization prior initiation study related procedure willing participate Known allergy ferumoxytol iron Individuals pregnant lactating Iron saturation upper limit normal Individuals counterindication MRI , presence metallic prosthesis implant metal device ( e.g. , infusion pump , defibrillator ) Individuals known clinical condition may lead iron overload include hemochromatosis , cirrhosis , sickle cell disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>type 1 diabetes</keyword>
	<keyword>magnetic resonance imaging</keyword>
	<keyword>insulitis</keyword>
	<keyword>ferumoxytol</keyword>
</DOC>